Beta Carotene & Lycopene Supplements Contract Manufacturer & Private Label Partner
KS Nutripharma provides formula development, ingredient selection, sampling, manufacturing, packaging and documentation support for softgels, capsules, tablets, gummies, powders and liquid supplements. Our R&D team evaluates carotenoid source, potency, delivery system, carrier compatibility, serving size, processing stability and packaging before commercial production.
At a Glance
- ✓ OEM / Private Label Available— custom beta-carotene-to-lycopene ratios under your brand
- ✓ MOQ from 1,000 finished retail units per SKU (powders and sachets); 3,000–5,000 units for softgels, capsules and tablets
- ✓ Lead Time:samples in 7–15 days; pilot batch 15–25 days; mass production 30–45 days
- ✓ Quality & Certifications: cGMP manufacturing; ISO 9001, ISO 22000, FSSC 22000 and HACCP; Halal and Kosher certified
- ✓ 6 Dosage Formats: softgels (2M+ units/day), capsules (5M+/day), tablets (12M+/day), gummies (2M+/day), powders and liquids
- ✓ Request a Quote: initial project response within one business day
Market-Informed Formula Concepts
The following formulas are development references rather than fixed or clinically validated finished products. Final amounts, label declarations, warnings and claims require feasibility, safety, stability and target-market review.
Reference Formula
- Vitamin A as beta-carotene: 450 mcg RAE
- Lycopene: 10 mg
- Vitamin E as specified tocopherol: 10 mg
- Tocotrienol complex: 25 mg
Potential Positioning
- Daily carotenoid nutrition
- Carotenoid and vitamin E complex
- General wellness formula
Recommended Format: Softgel
Declaration note: vitamin E, mixed tocopherols and tocotrienols are distinct ingredient systems and are declared separately — they must not be lumped together under a single IU figure.
Reference Formula
- Vitamin A as beta-carotene: 450 mcg RAE
- Lycopene: 10 mg
- Wheat- or rice-derived ceramide ingredient: 30 mg*
- Hyaluronic acid: 120 mg
- Astaxanthin: 4 mg
Potential Positioning
- Beauty-from-within
- Skin hydration nutrition
- Premium multi-active beauty formula
- Healthy skin appearance support
Recommended Formats: hard capsule, powder sachet, or a dual-format capsule-and-softgel pack. Because hyaluronic acid is typically a water-dispersible powder, this formula should not default to a single oil-based softgel.
*Ceramide amount depends on the branded ingredient’s active concentration and substantiated use level.
Reference Formula
- Lycopene: 15 mg
- Vitamin A as beta-carotene: 450 mcg RAE
- CoQ10: 100 mg
- Selenium: 55 mcg
Recommended Format: Softgel, subject to selenium-premix feasibility
Development Considerations
- CoQ10 solubility or suspension system
- Low-dose selenium content uniformity
- Carrier-oil selection
- Softgel fill weight
- Oxidation control
This formula should not be positioned as preventing or treating prostate disease.
Reference Formula
- Vitamin A as natural beta-carotene: 450 mcg RAE
- Lycopene: 5–10 mg
- Lutein: 10 mg
- Zeaxanthin: 2 mg
- Astaxanthin: 4 mg
- Mixed tocopherols: 10 mg
Potential Positioning
- Broad-spectrum carotenoid nutrition
- Multi-carotenoid complex
- Daily vision-nutrition concept
- Healthy-aging product line
Recommended Formats: softgel, capsule, or softgel-plus-capsule system
This formula is not an AREDS2 formula and should not be marketed as treating or preventing age-related eye disease.
| Ingredient | Common development range |
| Vitamin A from beta-carotene | 450–900 mcg RAE/day |
| Lycopene | 5–15 mg/day |
| Astaxanthin | 2–6 mg/day |
| Lutein | 10–20 mg/day |
| Zeaxanthin | 2–4 mg/day |
These ranges are formulation starting points rather than universal dosage recommendations. Final amounts depend on ingredient specification, target population, complete formula, scientific substantiation and destination-market requirements.
Delivery-System Comparison
| Delivery system | Technical characteristic | Potential formats |
| Oil suspension | Designed for oil-phase formulation | Softgels and oil-based liquids |
| Beadlets | Protected dry delivery system | Capsules, tablets and premixes |
| CWS powder | Water-dispersible microencapsulated system | Gummies, sachets and drink powders |
| Microencapsulated powder | Improved handling and environmental protection | Capsules, tablets and powders |
Beta-carotene delivery systems available from KS Nutripharma:
- Standard powder: 5%–96%, depending on source and product code — tablets, capsules and premixes
- CWS microencapsulated powder: 1% and 10% — gummies, drink powders, sachets and selected liquids
- Beadlets: 1% and 10% — tablets, capsules and premixes
- Oil suspension: 10%, 20% and 30% — softgels and oil-based liquid products
Exact availability must be confirmed by ingredient source and current specification. The selected beta-carotene system must be matched with a compatible lycopene material.
Softgels are commonly evaluated for oil-based carotenoid formulas because the active ingredients, carrier system and protective packaging can be developed as one integrated system.
Softgel customization:
- Custom beta-carotene-to-lycopene ratio
- Natural or selected synthetic-source options
- Carrier-oil options confirmed according to ingredient compatibility, allergen requirements and availability
- Antioxidant protection system
- Fill weight, softgel size and shape
- Shell color and opacity; gelatin or selected vegetarian shell options
- Bottle count; blister or secondary-carton packaging
- Additional fat-soluble ingredients
Technical development considerations:
- Ingredient potency and oil-phase compatibility
- Fill viscosity, suspension uniformity and sedimentation behavior
- Carrier-oil oxidation and active retention
- Shell compatibility, oxygen exposure and light protection
- Storage temperature and shelf-life requirements
Softgels should not automatically be described as providing superior absorption. Bioavailability depends on the ingredient form, carrier, complete formula, serving conditions and individual factors.
Hard capsules may be suitable when both carotenoids are available in compatible powder, beadlet or microencapsulated forms.
Capsule customization: capsule size and shell material (gelatin or vegetarian HPMC) · capsule color · powder or beadlet filling · single- or multiple-capsule serving · additional carotenoids, vitamins and minerals · bottle or blister packaging.
Feasibility factors: bulk density · flowability · particle-size compatibility · ingredient potency · fill-weight limitations · content uniformity · moisture sensitivity · light and oxygen protection.
Tablets may be evaluated for protected beadlets, microencapsulated powders and multivitamin-style formulas.
Tablet customization: custom carotenoid ratio · tablet size and shape · coated or uncoated format · additional vitamins and minerals · color-protective coating · bottle, blister or bulk packaging.
Feasibility factors: compression resistance · particle size · ingredient distribution · content uniformity · coating compatibility · processing stability · finished-product disintegration.
Powder formats may be possible using compatible water-dispersible or microencapsulated carotenoid ingredients.
Potential applications: stick packs · sachets · beauty drink powders · nutritional premixes · solid beverages · bulk powder blends.
Development considerations: water dispersibility · color intensity · flavor compatibility · sedimentation · processing temperature · oxygen and light exposure · packaging barrier · shelf-life stability.
A beta-carotene and lycopene gummy can provide a differentiated consumer format, but color, flavor and processing stability require careful evaluation.
Gummy customization: target serving amount · gummy size and shape · flavor system · natural or permitted color system · pectin or gelatin base · sweetener system · sugar-free concept assessment · bottle or pouch packaging.
Protected or microencapsulated carotenoid systems may be required depending on processing temperature and the target shelf life; active retention must be confirmed through pilot production and stability testing.
Lycopene ingredients can vary significantly in source, standardized potency, oil / beadlet / powder form, carrier system, isomer profile, dispersibility, color, processing stability and supporting documentation.
Before development, KS Nutripharma will confirm:
- Available lycopene source and specification
- Compatibility with the selected beta-carotene system
- Intended dosage form
- Target serving amount
- Required source and quality documents
- Target-market labeling requirements
Beta-carotene and lycopene belong to the carotenoid family but have different nutritional, sourcing and formulation characteristics.
Beta-carotene is a provitamin A carotenoid that the body can convert into vitamin A. Important development considerations include source, standardized potency, vitamin A contribution, target population, daily serving amount, delivery system (oil, powder, beadlet or CWS) and high-dose safety assessment.
Lycopene is a non-provitamin A carotenoid commonly obtained from standardized tomato ingredients. Important development considerations include tomato source, standardized lycopene content, oil / beadlet / protected-powder form, carrier composition, isomer profile, processing stability, and light and oxygen protection.
Formulation rationale — combining beta-carotene and lycopene can provide:
- A broader carotenoid ingredient profile
- Differentiation from single-ingredient products
- Natural-source product storytelling
- Flexible daily wellness and beauty concepts
- Compatibility with other carotenoids
- Expansion into mixed-carotenoid or multivitamin lines
No synergistic clinical benefit should be assumed without formula-specific evidence.
Compared with single-ingredient products, multi-carotenoid concepts can provide:
- A broader ingredient story
- Premium product positioning
- Greater formulation differentiation
- Compatibility with beauty and healthy-aging concepts
- Opportunities for multiple source and delivery formats
- Extension into softgel, capsule and powder product lines
Multi-carotenoid formulas do not automatically provide superior efficacy. Ingredient interactions, serving amounts, safety and evidence must be reviewed for the complete formula.
Carotenoids are used across dietary supplements, food and beverages, cosmetics, pharmaceuticals and animal nutrition.
According to Grand View Research, the global carotenoids market was valued at approximately USD 3.26 billion in 2024 and is projected to reach USD 5.22 billion by 2033, representing a compound annual growth rate of 5.4% from 2025 to 2033.
Product-development interest is being shaped by:
- Demand for natural-source ingredients
- Expansion of beauty-from-within supplements
- Healthy-aging product development
- Interest in mixed-carotenoid complexes
- Growth of plant-based wellness positioning
- Wider use of protected powders, beadlets and oil-based delivery systems
Euromonitor reported that beauty-positioned consumer health supplements grew by more than 6% in real terms in 2025, compared with approximately 2% for the broader consumer health industry.
These market observations describe category trends and do not establish the efficacy of any individual ingredient or finished formula. Market estimates vary by research scope, application coverage and methodology. KS Nutripharma is not affiliated with the cited research organizations.
Sources
- Grand View Research — Carotenoids Market: https://www.grandviewresearch.com/industry-analysis/carotenoids-market
- Euromonitor — Beauty-Positioned Consumer Health Supplements: https://www.euromonitor.com/navigating-rapid-growth-in-beauty-positioned-consumer-health-supplements/report
| Ingredient source | Ingredient profile | Potential applications |
| Dunaliella salina | Natural-source beta-carotene; profile depends on specification | Softgels, capsules, tablets |
| Blakeslea trispora | Fermentation-derived beta-carotene | Softgels, capsules, tablets, premixes |
| Palm mixed-carotene concentrate | Beta- and alpha-carotene-containing system | Softgels and oil-based products |
| Tomato oleoresin | Tomato-derived lycopene in an oil-based matrix | Softgels and oil-based liquids |
| Protected tomato lycopene | Stabilized powder or beadlet system | Capsules, tablets and powders |
The carotenoid composition of any source — including algal sources — must be confirmed against the applicable specification; a source name alone does not define the ingredient profile.
Natural-origin, vegan, Non-GMO and clean-label positioning is available only when supported by documentation for:
- Active ingredients
- Carriers
- Excipients
- Processing aids
- Capsule or softgel shell
- Flavor and color systems
- Finished-product manufacturing
A natural active ingredient does not automatically make the finished product vegan, Non-GMO or clean label.
Beta-carotene and lycopene are sensitive to environmental and processing conditions.
Fat-soluble delivery — the formulation team evaluates carrier-oil composition, ingredient solubility or suspension behavior, fill viscosity, oil stability and capsule-shell compatibility.
Oxidation control — potential controls include protected ingredient forms, controlled oxygen exposure, antioxidant protection systems, suitable headspace management and high-barrier packaging.
Isomer and active stability — processing and storage can influence the physical and chemical characteristics of carotenoid ingredients. The technical review may consider mixing temperature, holding time, light exposure, oxygen exposure, ingredient interactions and storage conditions.
Light protection — potential options include opaque softgel shells, amber or opaque bottles, high-barrier blister packs, secondary cartons, and light-protective labels and sleeves.
Finished-product verification — testing may include appearance, weight variation, content uniformity, active content, disintegration, microbiological requirements, heavy metals, physical stability, and accelerated or real-time stability. Final tests and acceptance criteria are defined in the agreed product specification.
Different carotenoids may interact during micelle formation and postprandial absorption. Human studies have observed short-term competition among certain carotenoids, but this did not necessarily reduce medium-term plasma carotenoid status.
The practical impact depends on ingredient amounts, ingredient matrix, carrier system, delivery timing, the complete formula and individual absorption differences. The beta-carotene-to-lycopene ratio should therefore be treated as a development variable rather than a universally recommended fixed ratio.
Bottles
- 30-count, 60-count, 90-count, 120-count
- Custom counts subject to production review
- Amber or opaque packaging may be recommended for light-sensitive carotenoid formulas
Blister Packs
- Standard or high-barrier blister materials
- Custom layouts subject to tooling and line compatibility
- Carton and insert options
Stick Packs
- Approximately 3–10 g per stick, subject to powder density and line capability
- Custom carton counts
- Sample and retail configurations
Bulk Packaging
- Bulk finished softgels, capsules or tablets
- Bulk powder packaging
- Food-grade inner liners
- Export cartons
- Customer-specified configurations
All packaging sizes, materials and minimum quantities require project confirmation.
Final claims must match the complete formula, daily serving, evidence and destination-market regulations.
KS Nutripharma does not recommend unsupported claims such as:
- Prevents cancer
- Prevents cardiovascular disease
- Treats prostate disease
- Treats eye disease
- Prevents macular degeneration
- Treats skin conditions
- Replaces sunscreen
- Provides oral sun protection
- Clinically proven without product-relevant evidence
Safer product descriptions may include:
- Daily carotenoid formula
- Mixed carotenoid complex
- Beauty-from-within concept
- Men’s daily nutrition
- Healthy-aging nutrition
- Natural-source vitamin A
- Formulated with selected carotenoids
All final consumer-facing wording requires market-specific review.
Higher-dose supplemental beta-carotene requires careful assessment. Clinical evidence has associated large supplemental amounts of beta-carotene with increased lung-cancer risk among certain populations, including current smokers, former smokers and people with occupational asbestos exposure.
Formula development should consider target consumer, proposed daily amount, vitamin A contribution, other dietary sources, required label warnings, destination-market rules, and scientific support for intended claims.
The brand owner remains responsible for final product, label and legal approval.
| Format | Typical MOQ (finished retail units/SKU) |
| Softgels | 3,000–5,000 |
| Capsules | 3,000–5,000 |
| Tablets | 3,000–5,000 |
| Gummies | 5,000–10,000 |
| Powders and sachets | 1,000–3,000 |
| Liquids | Typically 5,000–10,000, confirmed after review |
Standard lead times:
- Sample development: 7–15 days
- Pilot batch: 15–25 days
- Mass production: 30–45 days
- Rush production: subject to ingredient and production availability
Actual MOQ and lead time depend on formula complexity, raw-material availability, testing and packaging.
- Define Your Product— target market, product positioning, dosage form, initial quantity, packaging, target launch date.
- Select Ingredient Systems— beta-carotene source and potency, lycopene source and potency, delivery system, carrier composition, supporting documentation.
- Conduct a Feasibility Review— ingredient compatibility, serving size, fill weight, processing conditions, stability risks, packaging requirements.
- Prepare the Quotation— pricing based on formula, dosage form, ingredient source, testing plan, order quantity and packaging configuration.
- Develop Samples— samples are normally prepared within 7–15 days after requirements and materials are confirmed.
- Complete Pilot Production— recommended for new ingredient combinations, complex softgel systems, gummies, high-potency formulas and unusual packaging.
- Confirm Specifications and Packaging— the formula, product specification, artwork and packaging are approved before commercial manufacturing.
- Manufacture and Release— commercial production and batch release follow the agreed quality plan.
- More than 19 years of manufacturing experience
- 81,000+ m² cGMP-compliant manufacturing facility
- Two dedicated R&D centers
- Twelve automated production lines
- More than 260 professionals
- More than 500 brands served
- Products supplied to over 60 export markets
Daily production output: tablets 12+ million units · capsules 5+ million units · softgels 2+ million units · gummies 2+ million units · powders: bulk blending supported · liquids: high-volume filling supported
Capacities shown are facility-wide outputs under standard production configurations. Actual project throughput depends on formula, unit size, packaging, testing and line scheduling.
Certifications: ISO 9001 · ISO 22000 · FSSC 22000 · HACCP · Halal · Kosher — certificates can be provided with their applicable scope, issuing organization and validity period.
Manufacturing compliance: cGMP.
Depending on the formula, project stage and agreed quality plan, available documentation may include:
- Product specification
- Batch Certificate of Analysis
- Ingredient specifications and source statements
- Allergen and GMO statements
- Halal and Kosher documents
- Stability documentation
- Packaging specifications
- Export documents, where applicable
- Batch manufacturing summary or supporting records, subject to confidentiality and quality procedures
Carotenoid Formulation Support — We evaluate ingredient source, potency, carrier, compatibility, dosage form and packaging as one development system.
Multiple Delivery Formats — Develop softgels, capsules, tablets, gummies, powders and liquids through one manufacturing partner.
Dedicated R&D Resources — Two R&D centers support feasibility review, sample development, pilot production and commercial transfer.
Flexible Entry Quantities — MOQ options support product testing, market entry and established retail programs.
Scalable Manufacturing — Twelve automated production lines support commercial growth and high-volume requirements.
Export Experience — KS Nutripharma supports brands and distributors across more than 60 export markets.
Start Your Beta Carotene and Lycopene Project
Tell us your preferred dosage form, ingredient sources, target serving amount, initial quantity, packaging requirements and destination market. Our team will evaluate compatible ingredient systems and recommend an appropriate development path, with an initial project response within one business day.
Recommended RFQ fields:
- Name and business email
- Company and website
- Country and target market
- Preferred dosage form
- Product positioning
- Beta-carotene source preference
- Lycopene source preference
- Target serving amount
- Additional active ingredients
- Initial order quantity
- Packaging requirements
- Required certifications
- Target launch date
Scientific, Regulatory and Market References
- NIH Office of Dietary Supplements. Vitamin A and Carotenoids — Health Professional Fact Sheet.
- Tyssandier V, et al. Vegetable-borne lutein, lycopene, and beta-carotene compete for incorporation into chylomicrons, with no adverse effect on medium-term plasma carotenoid status.American Journal of Clinical Nutrition.
- Grand View Research. Carotenoids Market.https://www.grandviewresearch.com/industry-analysis/carotenoids-market
- Beauty-Positioned Consumer Health Supplements.https://www.euromonitor.com/navigating-rapid-growth-in-beauty-positioned-consumer-health-supplements/report
- Relevant destination-market labeling and dietary-supplement regulations should be reviewed before product launch.
